AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11716099 — intervention group
Group type: EXPERIMENTAL
Intervention: Paromomycin plus methylbenzethonium chloride ointment
Number of subjects: 68
Study 9136830 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 pmol x kg(‐1) x h(‐1) of PYY
Number of subjects: 6
Study 9136830 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 pmol x kg(‐1) x h(‐1) of PYY
Number of subjects: 6
Study 9136830 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 6
Study 7971101 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical axis of symmetry
Number of subjects: 0
Study 7971101 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal axis of symmetry
Number of subjects: 0
Study 7971101 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagonal axes of symmetry
Number of subjects: 0
Study 7971101 — intervention group
Group type: EXPERIMENTAL
Intervention: Range of stimuli presented
Number of subjects: 0
Study 3672087 — intervention group
Group type: EXPERIMENTAL
Intervention: Broncho-Vaxom
Number of subjects: 33
Study 3672087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 31930663 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimplantation genetic testing for aneuploidy (PGT-A) by polar body biopsy and array-based comprehensive genome hybridisation (aCGH)
Number of subjects: 0
Study 31930663 — intervention group
Group type: COMPARATOR
Intervention: Regular IVF/ICSI without PGT-A
Number of subjects: 0
Study 31930663 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimplantation genetic testing for aneuploidy (PGT-A)
Number of subjects: 0
Study 30648920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile wellness intervention with Fitbit, daily motivational text messaging, and biweekly counseling for 12 weeks
Number of subjects: 79
Study 30648920 — intervention group
Group type: COMPARATOR
Intervention: Fitbit only
Number of subjects: 79
Study 28275109 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded Exercise (GE)
Number of subjects: 24
Study 28275109 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Exercise (IE)
Number of subjects: 24
Study 28275109 — intervention group
Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 24
Study 28275109 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (GE, IE, UC)
Number of subjects: 24
Study 24403296 — intervention group
Group type: EXPERIMENTAL
Intervention: CBC risk score tertile 3
Number of subjects: 17197
Study 24403296 — intervention group
Group type: EXPERIMENTAL
Intervention: CBC risk score tertile 2
Number of subjects: 17197
Study 24403296 — intervention group
Group type: EXPERIMENTAL
Intervention: CBC risk score tertile 3 (after adjustment)
Number of subjects: 17197
Study 24403296 — intervention group
Group type: EXPERIMENTAL
Intervention: CBC risk score tertile 2 (after adjustment)
Number of subjects: 17197
Study 24403296 — intervention group
Group type: EXPERIMENTAL
Intervention: CBC risk score
Number of subjects: 17197
Study 23124255 — intervention group
Group type: EXPERIMENTAL
Intervention: ProDisc-C (TDR)
Number of subjects: 209
Study 23124255 — intervention group
Group type: COMPARATOR
Intervention: ACDF
Number of subjects: 209
Study 23124255 — intervention group
Group type: EXPERIMENTAL
Intervention: TDR
Number of subjects: 209
Study 23124255 — intervention group
Group type: COMPARATOR
Intervention: ACDF and TDR
Number of subjects: 209
Study 20453699 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative blood products per kg (highest tertile)
Number of subjects: 270
Study 20453699 — intervention group
Group type: EXPERIMENTAL
Intervention: Any blood products on postoperative day 1
Number of subjects: 270
Study 18272844 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet
Number of subjects: 34
Study 18272844 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan monotherapy
Number of subjects: 34
Study 18272844 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet + Losartan
Number of subjects: 34
Study 18272844 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCT) + Losartan
Number of subjects: 34
Study 18272844 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet + HCT + Losartan
Number of subjects: 34
Study 16946613 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement restorations (aged)
Number of subjects: 16
Study 16946613 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement restorations (unaged)
Number of subjects: 16
Study 16946613 — intervention group
Group type: COMPARATOR
Intervention: Resin composite restorations (aged)
Number of subjects: 16
Study 16946613 — intervention group
Group type: COMPARATOR
Intervention: Resin composite restorations (unaged)
Number of subjects: 16
Study 14512149 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 8
Study 14512149 — intervention group
Group type: COMPARATOR
Intervention: Brotizolam (0.25 mg)
Number of subjects: 8
Study 14512149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 10637406 — intervention group
Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory (BDI) applied to subjects with probable AD and depression
Number of subjects: 186
Study 10637406 — intervention group
Group type: COMPARATOR
Intervention: Beck Depression Inventory (BDI) applied to subjects with probable AD without depression
Number of subjects: 186
Study 9577009 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolperisone HCL (Mydocalm) 150 mg twice daily for 12 weeks
Number of subjects: 72
Study 9577009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 9577009 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolperisone HCL (Mydocalm)
Number of subjects: 72
Study 8449072 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (10 to 20 mg given three times a day)
Number of subjects: 11
Study 8449072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 3092311 — intervention group
Group type: EXPERIMENTAL
Intervention: IGIV pH 4.25
Number of subjects: 39
Study 3092311 — intervention group
Group type: COMPARATOR
Intervention: IGIV pH 6.8
Number of subjects: 39
Study 30005948 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV7‐TT
Number of subjects: 30
Study 30005948 — intervention group
Group type: COMPARATOR
Intervention: Synflorix®
Number of subjects: 30
Study 27284930 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (MCP) 10 mg orally
Number of subjects: 8
Study 24752831 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyzetimibe (HS-25) 10 mg once daily for 10 days
Number of subjects: 0
Study 24752831 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyzetimibe (HS-25) 5, 10, and 20 mg (multiple ascending doses)
Number of subjects: 0
Study 24752831 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyzetimibe (HS-25) 1, 3, 5, 10, 20, and 30 mg (single ascending doses)
Number of subjects: 0
Study 24752831 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyzetimibe (HS-25)
Number of subjects: 0
Study 22345094 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg once daily added to losartan 100 mg once daily plus optimal antihypertensive therapy
Number of subjects: 599
Study 22345094 — intervention group
Group type: COMPARATOR
Intervention: Placebo added to losartan 100 mg once daily plus optimal antihypertensive therapy
Number of subjects: 599
Study 20819472 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic turbinoplasty
Number of subjects: 150
Study 20819472 — intervention group
Group type: COMPARATOR
Intervention: Laser-assisted turbinoplasty
Number of subjects: 150
Study 17095135 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal LMA-ProSeal (PLMA)
Number of subjects: 0
Study 17095135 — intervention group
Group type: COMPARATOR
Intervention: Neonatal classic laryngeal mask airway (cLMA)
Number of subjects: 0
Study 16378559 — intervention group
Group type: EXPERIMENTAL
Intervention: Care by GPwSIs in practices
Number of subjects: 321
Study 16378559 — intervention group
Group type: COMPARATOR
Intervention: Care by GPwSIs in hospital outpatient departments
Number of subjects: 321
Study 11923490 — intervention group
Group type: EXPERIMENTAL
Intervention: Undiluted smallpox vaccine (10^8.1 pfu/ml)
Number of subjects: 680
Study 11923490 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:5 diluted smallpox vaccine (10^7.2 pfu/ml)
Number of subjects: 680
Study 11923490 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:10 diluted smallpox vaccine (10^7.0 pfu/ml)
Number of subjects: 680
Study 11923490 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (undiluted and diluted vaccines)
Number of subjects: 680
Study 9616521 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen concentrators
Number of subjects: 26
Study 9616521 — intervention group
Group type: COMPARATOR
Intervention: Cylinders
Number of subjects: 26
Study 8133536 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/d)
Number of subjects: 4063
Study 8133536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4063
Study 8133536 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (randomized group)
Number of subjects: 4063
Study 2675299 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodilution therapy
Number of subjects: 106
Study 2675299 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 106
Study 126848 — intervention group
Group type: EXPERIMENTAL
Intervention: Azapropazone (300 mg, 4-times daily)
Number of subjects: 50
Study 126848 — intervention group
Group type: COMPARATOR
Intervention: Ketoprofen (50 mg, 4-times daily)
Number of subjects: 50
Study 126848 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intermediate period)
Number of subjects: 50
Study 31356511 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbell Hip Thrust (BHT)
Number of subjects: 8
Study 31356511 — intervention group
Group type: EXPERIMENTAL
Intervention: Back Squat (SQ)
Number of subjects: 8
Study 31356511 — intervention group
Group type: EXPERIMENTAL
Intervention: Romanian Deadlift (RDL)
Number of subjects: 8
Study 27840252 — intervention group
Group type: EXPERIMENTAL
Intervention: ERSPC risk calculator (RC) for prostate cancer
Number of subjects: 749
Study 27840252 — intervention group
Group type: EXPERIMENTAL
Intervention: ERSPC risk calculator (RC) for significant PCa
Number of subjects: 749
Study 27840252 — intervention group
Group type: EXPERIMENTAL
Intervention: ERSPC risk calculator (RC) for unnecessary biopsies
Number of subjects: 749
Study 27840252 — intervention group
Group type: EXPERIMENTAL
Intervention: Variability of ERSPC risk calculator (RC)
Number of subjects: 749
Study 26940016 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (8-week program)
Number of subjects: 29
Study 26940016 — intervention group
Group type: COMPARATOR
Intervention: Control group (daily routines)
Number of subjects: 29
Study 25198082 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase ointment (CO)
Number of subjects: 10
Study 25198082 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine (SSD)
Number of subjects: 10
Study 22143991 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-balloon endoscopy (DBE)
Number of subjects: 94
Study 22143991 — intervention group
Group type: COMPARATOR
Intervention: Magnet-imaging enhanced colonoscopy with cap (MEI-Cap)
Number of subjects: 94
Study 20179636 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral beclomethasone dipropionate (BDP) 5 mg/day for 8 weeks
Number of subjects: 30
Study 20179636 — intervention group
Group type: COMPARATOR
Intervention: Oral 5-aminosalicylate (5‐ASA) 80 mg/kg/day
Number of subjects: 30
Study 20179636 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 30
Study 17394636 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and activation program (EAP) administered by trained GPs.
Number of subjects: 10
Study 17394636 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) administered by GPs.
Number of subjects: 10
Study 16236947 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual hyperinflation (MH) technique at a rate of 8 to 13 breaths/min for 20 min each session, three times per day for 5 days
Number of subjects: 23
Study 16236947 — intervention group
Group type: COMPARATOR
Intervention: Standard prescribed mechanical ventilation without supplemental MH
Number of subjects: 23
Study 11960957 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at varying intensities (25% and 75% of the difference between lactate threshold and rest, at lactate threshold, and at 25% and 75% of the difference between lactate threshold and peak O2 uptake) for 30 minutes
Number of subjects: 8
Study 11960957 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (Ex)
Number of subjects: 8
Study 11960957 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 8
Study 10212618 — intervention group
Group type: EXPERIMENTAL
Intervention: Anteroinferior pin purchase with AO frame
Number of subjects: 5
Study 10212618 — intervention group
Group type: EXPERIMENTAL
Intervention: Anteroinferior pin purchase with Orthofix
Number of subjects: 5
Study 10212618 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterosuperior pin purchase with AO frame
Number of subjects: 5
Study 10212618 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterosuperior pin purchase with Orthofix
Number of subjects: 5
Study 10212618 — intervention group
Group type: EXPERIMENTAL
Intervention: Anteroinferior location of pin purchase
Number of subjects: 5
Study 10212618 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissection of preinserted anatomic specimen
Number of subjects: 5
Study 7836337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg once daily, titrated to a maximum of 200 mg)
Number of subjects: 113
Study 7836337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 113
Study 1839437 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 74
Study 1839437 — intervention group
Group type: COMPARATOR
Intervention: Nitrendipine
Number of subjects: 74
Study 6187544 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep deprivation (24 hours)
Number of subjects: 69
Study 6187544 — intervention group
Group type: COMPARATOR
Intervention: Secobarbital-induced sleep
Number of subjects: 69
Study 6187544 — intervention group
Group type: EXPERIMENTAL
Intervention: Waking state
Number of subjects: 69
Study 30729333 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D vaginal suppositories
Number of subjects: 96
Study 30729333 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E vaginal suppositories
Number of subjects: 96
Study 30729333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 30197282 — intervention group
Group type: EXPERIMENTAL
Intervention: Tdap-B
Number of subjects: 809
Study 30197282 — intervention group
Group type: EXPERIMENTAL
Intervention: Tdap-A
Number of subjects: 809
Study 30197282 — intervention group
Group type: COMPARATOR
Intervention: Tdap-B and Tdap-A
Number of subjects: 809
Study 26813753 — intervention group
Group type: EXPERIMENTAL
Intervention: Stirrup brace
Number of subjects: 18
Study 26813753 — intervention group
Group type: EXPERIMENTAL
Intervention: Walker boot
Number of subjects: 18
Study 26813753 — intervention group
Group type: COMPARATOR
Intervention: Tubigrip
Number of subjects: 18
Study 27502042 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous mitral valve repair (PMVR)
Number of subjects: 58
Study 23824645 — intervention group
Group type: EXPERIMENTAL
Intervention: sorafenib (400 mg twice daily)
Number of subjects: 52
Study 23824645 — intervention group
Group type: COMPARATOR
Intervention: capecitabine (1,000 mg/m2 twice daily, day 1-day 14)
Number of subjects: 52
Study 22046601 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive referral
Number of subjects: 245
Study 22046601 — intervention group
Group type: EXPERIMENTAL
Intervention: Contract referral
Number of subjects: 245
Study 22046601 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider referral
Number of subjects: 245
Study 22046601 — intervention group
Group type: EXPERIMENTAL
Intervention: Returning partners (n = 107)
Number of subjects: 245
Study 19844125 — intervention group
Group type: EXPERIMENTAL
Intervention: Omnitrope((R)) lyophilisate (group A, n = 44)
Number of subjects: 89
Study 19844125 — intervention group
Group type: COMPARATOR
Intervention: Genotropin((R)) (group B, n = 45)
Number of subjects: 89
Study 19844125 — intervention group
Group type: EXPERIMENTAL
Intervention: Omnitrope((R)) liquid
Number of subjects: 89
Study 19844125 — intervention group
Group type: COMPARATOR
Intervention: Genotropin((R)) switched to Omnitrope((R)) liquid
Number of subjects: 89
Study 17096182 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 13
Study 17096182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 14991587 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear cell RCC
Number of subjects: 5
Study 14991587 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromophobe RCC
Number of subjects: 5
Study 11699068 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms of rhIFN-gamma subcutaneously (treated group, n = 24)
Number of subjects: 46
Study 11699068 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group, n = 22)
Number of subjects: 46
Study 11699068 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIFN-gamma (treated group)
Number of subjects: 46
Study 9043722 — intervention group
Group type: EXPERIMENTAL
Intervention: Group BAL (alfentanil/N2O)
Number of subjects: 93
Study 9043722 — intervention group
Group type: EXPERIMENTAL
Intervention: Group INH (isoflurane/fentanyl/N2O)
Number of subjects: 93
Study 9043722 — intervention group
Group type: EXPERIMENTAL
Intervention: Group TIVA (propofol/alfentanil/O2)
Number of subjects: 93
Study 8551442 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined phacoemulsification and trabeculotomy ab externo
Number of subjects: 106
Study 8551442 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification alone with IOL implantation
Number of subjects: 106
Study 1699628 — intervention group
Group type: EXPERIMENTAL
Intervention: Cernilton (pollen extract) for 6 months
Number of subjects: 60
Study 1699628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 368299 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.3 mg/kg at admission and a similar dose 2 hours later)
Number of subjects: 30
Study 368299 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 30
Study 30958325 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual assessment using light microscopy
Number of subjects: 27
Study 30958325 — intervention group
Group type: COMPARATOR
Intervention: Digital image analysis from one central laboratory
Number of subjects: 27
Study 28214392 — intervention group
Group type: EXPERIMENTAL
Intervention: RNC cigarette advertisement
Number of subjects: 77
Study 28214392 — intervention group
Group type: EXPERIMENTAL
Intervention: RNC cigarette use (0.6mg nicotine yield)
Number of subjects: 77
Study 25587091 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge summaries completed on the day of discharge
Number of subjects: 1640
Study 25587091 — intervention group
Group type: EXPERIMENTAL
Intervention: Documented transmission to the follow-up physician
Number of subjects: 1640
Study 25587091 — intervention group
Group type: EXPERIMENTAL
Intervention: Content quality based on Transitions of Care Consensus Conference elements
Number of subjects: 1640
Study 25587091 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of hospital course in discharge summaries
Number of subjects: 1640
Study 25587091 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of discharge condition in discharge summaries
Number of subjects: 1640
Study 25587091 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of discharge volume status in discharge summaries
Number of subjects: 1640
Study 25587091 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of discharge weight in discharge summaries
Number of subjects: 1640
Study 25587091 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall quality of discharge summaries
Number of subjects: 1640
Study 23719070 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 59
Study 23719070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 59
Study 23719070 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 59
Study 21333314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone treatment
Number of subjects: 26
Study 21333314 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 26
Study 19589901 — intervention group
Group type: EXPERIMENTAL
Intervention: High intermittent dose of liposomal amphotericin B (10 mg kg(‐1) on day 1, 5 mg kg(‐1) on days 3 and 6)
Number of subjects: 60
Study 19589901 — intervention group
Group type: COMPARATOR
Intervention: Standard daily dose of liposomal amphotericin B (3 mg kg(‐1) per day for 14 days)
Number of subjects: 60
Study 19589901 — intervention group
Group type: EXPERIMENTAL
Intervention: High intermittent dose of liposomal amphotericin B
Number of subjects: 60
Study 19589901 — intervention group
Group type: COMPARATOR
Intervention: Standard daily dose of liposomal amphotericin B
Number of subjects: 60
Study 19589901 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 60
Study 17116219 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 1000 mg (500 mg bid.) on the first treatment day, increased to 2000 mg (1000 mg bid.) from the second day onward.
Number of subjects: 23
Study 17116219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 15589082 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care management strategies including prescribed medications for pain management (54.21% of participants used this strategy).
Number of subjects: 150
Study 15589082 — intervention group
Group type: EXPERIMENTAL
Intervention: Training nursing home staff to perform regular pain assessments and provide knowledge about pain assessment and management strategies.
Number of subjects: 150
Study 11733289 — intervention group
Group type: EXPERIMENTAL
Intervention: BiPAP ventilation plus standard treatment
Number of subjects: 35
Study 11733289 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone (non-BiPAP)
Number of subjects: 35